Summary
Velorum Therapeutics develops cancer drugs that starve tumors by removing heme, a molecule cancers steal from blood to fuel growth. Founded by twin brothers Parsa and Pouya Modareszadeh, who spent five years studying cancer metabolism, they amplify the body's natural heme removal system using evolved proteins. Their drugs have shown effectiveness in mice across multiple cancer types without harming healthy cells, and they plan to begin human clinical trials next year starting with lung cancer.
